2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on AML: Is Ivosidenib + BCL2 Inhibitor Venetoclax +/- Azacitidine Effective for Patients With IDH1-Mutated AML?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Tapan Kadia
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Tapan Kadia
199 views
July 22, 2020
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology